Investing with DARA

Dara operates successfully by acquiring promising therapeutic molecules and medical technologies directly or through investment in established companies.  With this unique structure and strategic model, DARA offers two avenues for returns for its investors.

DARA’s development and liquidity strategy for each entity will vary depending on market conditions, stage of development, the target profile of product candidates in the pipeline and the competitive market dynamic.

The DARA Biosciences senior management team has substantial experience in the formation of biopharmaceutical and medical device companies. They understand how the development and commercialization processes come together to build a successful pharmaceutical brand. Collectively, the leadership team has formed more than 10 companies that have launched successful products and provided a significant return to its investors.  

At DARA BioSciences, we believe that our extensive due diligence process has yielded an exceptional pipeline of candidates that can alter the course of medicine and help patients in need. At DARA BioSciences, we are committed to advancing medical discoveries.

For more information about DARA, please contact investorrelations@darabiosciences.com.